Annette Marcantonio
Corporate Officer/Principal presso JASPER THERAPEUTICS, INC.
Posizioni attive di Annette Marcantonio
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| JASPER THERAPEUTICS, INC. | Corporate Officer/Principal | 02/08/2023 | - |
Storia della carriera di Annette Marcantonio
Precedenti posizioni note di Annette Marcantonio
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Neurogastrx, Inc.
 Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Corporate Officer/Principal | 01/09/2021 | 01/12/2022 |
| AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/09/2016 | 01/10/2020 |
Formazione di Annette Marcantonio
| Loyola Marymount University | Undergraduate Degree |
| University of Phoenix | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| JASPER THERAPEUTICS, INC. | Finance |
| Aziende private | 2 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
Neurogastrx, Inc.
Neurogastrx, Inc. BiotechnologyHealth Technology Neurogastrx, Inc. operates as a venture-stage biopharmaceutical company. The firm develops biopharmaceutical products for the treatment of gastrointestinal disorders. It offers NG101, a product for the treatment of gastroparesis. The company was founded by Cyril De Colle and Pankaj Jay Pasricha and is headquartered in Campbell, CA. | Health Technology |
- Borsa valori
- Insiders
- Annette Marcantonio
- Esperienza
